- Hiring, pay and restructuring: 4 HR leaders on difficult workforce decisions
- First free dental clinic opens in New Jersey
- The week in hospital M&A
- 5 dental insurance changes dentists need to know from the past 15 days
- A new medical school is opening nearby. What do health systems do first?
- ‘Snowbirds’ and ‘med-à-terres’: The market behaviors shaping systems’ growth decisions
- Indiana dental office manager sentenced to 36 months in prison for Medicaid fraud
- OpenAI says new ChatGPT model tops physician-written health answers
- CMS’ accreditation overhaul: What it means for hospitals
- Eli Lilly begins denying 340B discounts
- 5 cardiology leaders building the ASC ownership model
- What it actually takes to launch cardiac ablations in an ASC
- 5 federal, state legislative updates affecting the dental workforce
- Ebola cases jump 38% in 1 week: 5 things to know
- 34 recent hospital, health system executive moves
- Hospitals and health systems moving to new EHR platforms
- How many dentists the largest DSOs support
- 8 new behavioral health projects to know
- Anesthesia has a usage problem not a workforce shortage, leaders say
- Remain or Reimagine: Free Interactive Tool Shows Dentists the value of remaining independent vs partnering with Elevate
- Pennsylvania dental group settles patient coverage lawsuit for $1M
- Pennsylvania physicians push back on consolidation with first-ever independent practice summit
- The ASC procedure list is growing — here’s what’s still missing
- wRVU pay, hospital subsidies don’t constitute Stark law fraud, court rules
- Specialty dentists’ compensation has climbed 39% since 2019
- ASCs’ block time hoarding problem
- Oregon prosecutors urge state to fix mental health system
- Arkansas lab pays $30M to settle kickback allegations tied to gastroenterology practices
- The case for layering behavioral healthcare models
- Why dentistry needs a revamp
- Rural, independent Kansas hospitals launch clinically integrated network
- Nova Southeastern launches 1st anesthesiologist assistant program in Nevada
- 12 behavioral health services, facility closures | 2026
- Higher, short-acting opioid doses linked to 8% lower discharge risk: 4 notes
- Cardiologists push back on CMS’ proposed pay policy changes
- 14,700 bottles of antidepressant recalled over impurity concerns
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- 7 DSOs making headlines
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- How Northwell is using paramedics to close behavioral healthcare gaps
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Readers Curse Medical Debt and Defend Spelling Therapy
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- 20 new behavioral health study findings to know
- 31 behavioral health executive moves to know
- Centerstone names COO
- One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- OhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuit
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- OIG report raises red flags about maternal health 'ghost networks' in Medicaid managed care
- Lantern, Marathon Health team up to launch integrated care management model
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- Whoop, HealthEx partner to connect members’ medical records and biometric data
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- After FDA sign-off, Colorado's drug import plan faces tough road ahead
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Why one life insurer is going big on health incentives
- Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI tool for healthcare marketers
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Health services deal value holds steady in 2026 with higher bar for investment: PwC
- CMS tightens oversight of accreditation organizations, limits fee-based consulting
- MedPAC offers a look at enrollment hiccups for Medicare beneficiaries
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- 'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- US telehealth utilization climbs 10.1% in Q1, led by mental health visits: Fair Health
- FDA, UK drug regulator deepen transatlantic ties with new liaison program
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom
- Uncovr secures $7M in seed funding for AI surgical documentation platform
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund
- Early-Onset Cancers Are on the Rise. Knowing Your Family History Is Crucial.
- Stealth BioTherapeutics removes cloak to become Mighty
- Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand
- DeepIntent gives Helix an AI twist to help marketers query data
- PhRMA talks up the power of ‘Medicines First’ in new campaign
- Centene offering staff buyouts as it navigates murky ACA waters
- KFF: Insurer participation in the ACA marketplaces declined from 2025 to 2026
- Organic Baby Formula Recalled Following Botulism Cases
- Germany backs off plan to install variable discount pricing on drugs: report
- Judge tosses multiple provisions of CMS' 2025 ACA program integrity rule
- FDA Approves First Over-the-Counter Glucose Monitor for Children, The Stelo Glucose Biosensor System
- You've Won The Game
- IQVIA taps AI to put overlooked prescribers on marketers’ maps
- Many Patients Stop And Restart GLP-1 Meds, Study Finds
- Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod
- Sanofi, once on FDA course for speedy approval, gains late expansion for Tzield
- Half Of U.S. Parents Track Their Adult Children’s Location
- Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting
- Trust In CDC Plummets Under Trump Administration, New Poll Shows
- Fentanyl Users Take Daily Doses 60 Times The Lethal Level
- Final Rules For Medicaid Work Requirements Are Out. Here's What You Need To Know.
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Influencers, Booze And Teens: What's Showing Up In Their Feeds?
- Health 'War Room,' Digital Tools Are Tracking Disease Risks During World Cup
- Food Labels and Restrictions Can Lower Childhood Obesity Rates, Study Finds
- Tourette Patients Face High Suicide Risk, Pain And Discrimination
- Have A Risk-Taking Teen? This Brain Chemical Might Be Responsible, Researchers Say
- Sepsis, Lung Infection Patients See No Benefit From Remote Monitoring
- Overlooked Social Connections Can Prevent Suicide
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Vitamin C May Be Key To A Healthier Brain As You Age
- New Vaccine Schedule Released By American College of Obstetricians & Gynecologists
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Can Fasting Treat Gum Disease? Study Finds Reduced Inflammation
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- How lab data powers precision commercialization to drive therapy adoption
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
- Base Case: Remarks at the IC3 Blockchain Camp
- Eli Lilly cuts 340B discounts for hospitals resisting its claims data submission policy
Michigan healthcare freedom community forum
As usual, politics in 2024 is an upside-down world. He said, she said, who knows where the truth lives amid the lies?
The Gateway Pundit published one of the clearest statements I've seen yet regarding the presidential candidates and their positions on abortion.
Practical federalism at its finest.
https://www.thegatewaypundit.com/2024/08/frank-pavone-lets-stop-asking-wrong-questions-about/
Quote]
Frank Pavone: Let’s Stop Asking the Wrong Questions About Trump and Abortion
Recent headlines are all about Vice Presidential candidate J.D. Vance predicting on a Sunday morning talk show that, if re-elected, President Donald Trump would veto any national bill banning abortion.
As is so often the case with the legacy media, they were asking the wrong question.
So asking a question like NBC’s Kristen Welker asked is setting up a scenario that is totally devoid of reality.
Another unlikely scenario is a Democrat-controlled Congress sending to Trump the Women’s Health Protection Act, a radical piece of legislation that would undo every pro-life law in the nation.
I wonder why they didn’t ask about that.
I am still waiting for the interview in which the media ask about the actual pro-life measures that will be within the President’s power from day one, all of which he did in his first term. For instance:
- Will you reinstate the expanded Mexico City policy, which so efficiently kept U.S. tax dollars from flowing to abortion profiteers overseas?
- Will you reinstate the rule barring any organization that receives Title X funds for family planning from discussing abortion with their clients?
- Will you continue to appoint federal judges who understand that the right to life is fundamental to our Constitution?
- Will you have the United States once again sign on to the life-affirming Geneva Consensus Declaration?
- Will you again defund the U.N. Population Fund (UNFPA), which peddles abortion ideology in 150 nations?
- Will you reinstate the office of Conscience and Religious Freedom within the Department of Health and Human Services?
But, of course, the Trump-hating media are not interested in making the President seem reasonable to pro-life and pro-choice people alike, by reminding them that he supports pro-life measures that most Americans likewise support.
Anti-Trumpers don’t want to remind pro-life people of what he actually accomplished, because that might encourage rather than suppress the pro-life vote.
We already have the tools we need to change public policy in a second Trump term to better protect the unborn.
We need freedom of speech, so we can educate people on abortion; freedom of religion to activate churches to protect the unborn; freedom of assembly to allow for pro-life marches, rallies, protests and prayer vigils; and, importantly, existing pro-life laws, which actually keep some money away from abortion businesses and protect some babies.
These tools already are in our arsenal, but the Democrats want to take them away from us. They’re throwing peaceful pro-lifers in prison, censoring pro-life speech, trying to shut down pregnancy centers and canceling pro-life politicians.
President Trump is the best person to protect the tools we need in order to end abortion. We don’t need him to give pro-life speeches or commit to signing bills – like a national ban on abortion – that aren’t going to come to his desk in the first place.
We have to get him elected, because if the Democrats have their way, the pro-life movement will not have the political freedom to protect any babies.
And yet here we are, over the weekend and today, arguing on social media and in the press about whether we can support President Trump because, as some say, he’s “backing away” from the pro-life position.
In reality, the choice before us is not between President Trump and somebody better. It’s between President Trump and somebody worse. It’s between President Trump, who made it possible for states to protect the unborn, as many of them now do and will continue to do, and Kamala Harris, who wants to take away the ability of states to protect the unborn by making abortion a fundamental constitutional right.
I often say that mothers do not choose abortion because they have freedom of choice, but because they have no freedom and no choice. In this election, if we want to preserve our freedom to protect life, there is only one choice.
This Daily Signal commentary defends federalist strategy + pro-life goals in a way I haven't seen elsewhere. I like it: it makes me feel conservatives are regaining some of the ground that is their constitutional heritage.
https://www.dailysignal.com/2024/11/15/3-pro-life-policies-watch-trumps-second-term/
3 Pro-Life Policies to Watch for in Trump’s Second Term
Donald Trump is the most pro-life president in U.S. history. No other leader of the free world has matched his commitment to defending life, from defunding abortion providers to decisively reshaping the Supreme Court.
As we look to a second Trump term, two pro-life policies are likely to take center stage and immediately should be adopted.
A third—a national abortion ban—is not likely to get traction at this time.
1. Defund Planned Parenthood
Under President Joe Biden, Planned Parenthood received a record $750 million of taxpayer funding while performing a record 392,000 abortions just last year. The so-called nonprofit now gets roughly one-third of its total income from the federal government.
Defunding Planned Parenthood would be a major setback for the organization, which has already shown signs of mission drift and ineffective leadership in the post-Roe v. Wade era.
Since Cecile Richards left in 2018 after 12 years at the helm, the role of CEO at Planned Parenthood has become a chaotic evolving door, and the overturning of Roe didn’t help. The current leadership has been less effective in executing Planned Parenthood’s mission, as confirmed by both current and former employees.
In 2017, Trump sought to defund Planned Parenthood, but was blocked by then-Speaker of the House Paul Ryan and other Republicans lacking the political will and moral clarity to make it happen.
He revisited the idea in 2019 through Title X, which provides government funding to Planned Parenthood to distribute contraceptives and other so-called family planning. Just last month, shortly before the election, then-vice presidential candidate Sen. JD Vance, R-Ohio, affirmed the Republican ticket’s goal to defund Planned Parenthood under a second Trump administration.
This move also aligns with Trump’s stance that abortion is now a state issue and, therefore, federal funding should not be supporting it. Like many other nonprofits in the nation, Planned Parenthood should fund itself, rather than relying on federal handouts.
Additionally, we can expect Trump to both cut funding for Planned Parenthood International—Planned Parenthood’s arm in foreign countries—as he did in his first term, and reinstate the Mexico City Policy, one of his first actions as president in 2017, to prevent U.S. taxpayer dollars from funding overseas abortions.
2. Reregulating Abortion Pills
Following the overturning of Roe, the Centers for Disease Control and Prevention and the Food and Drug Administration dramatically expanded access to abortion pills by permitting them to be dispensed through pharmacies and even by mail, without requiring any in-person medical oversight.
Removing the need for a visit to a medical professional before taking these pills hardly qualifies as safe health care, likely contributing to the fact that 1 out of every 21 women who take them end up in the emergency room.
Reinstating basic regulations on abortion pills is a commonsense measure that even pro-abortion advocates once supported. Not least given the revelation of alarming medical statistics, it stands a strong chance of gaining traction with a Republican majority in Congress.
3. A National Abortion Ban
Since the Supreme Court chose not to apply the 14th Amendment to unborn children, abortion has been returned to the states. Although a federal abortion ban was quickly brought into the conversation, Trump has consistently stated he would not pursue one, and there’s no reason to expect he’d go back on his word.
Calls for a 15-week ban—an arbitrary gestational threshold—were considered, but ultimately rejected, by Trump. In a post-Roe America, where 25 states have already enacted strong pro-life laws, a 15-week ban would undermine their more protective legislation already in place, signaling weakness rather than progress. A 15-week ban would become the standard in all of those pro-life states that have already saved tens of thousands of babies with stricter bans or heartbeat bills that prevent abortions after six weeks of pregnancy.
Trump is sometimes accused of not listening to advisers, but the pro-life movement’s experience has shown otherwise. As a candidate, Trump admitted his limited knowledge of abortion, but took the time to educate himself. He listened to pro-life champions and accepted critical guidance from Federalist Society Chairman Leonard Leo and other Catholic leaders on Supreme Court nominations. This led directly to the overturning of Roe, an event many pro-life Americans never thought they’d witness.
In a second term, Trump is poised to remain a steadfast pro-life president. While pro-life Americans shouldn’t give him a free pass, it would be reckless and disrespectful to ignore his remarkable record.
Trump has demonstrated his commitment to the pro-life cause, and there’s every reason to believe he will govern with those values at the forefront once again.
Shawn Carney is president and CEO of the pro-life organization 40 Days for Life and the author of “What to Say When 2: Your Proven Guide in the New Abortion Landscape.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















